In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to ...
Pfizer (PFE) has entered into an agreement with Boltz to use the latter's biomolecular AI foundation models to tap into the ...
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
Boltz has raised $28 million in fresh funding while entering a strategic partnership with Pfizer that underscores the accelerating push by major drugmakers to embed artificial intelligence deeper into ...